Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients With Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials . J of Skin 2024, 8 (2), s375. https://doi.org/10.25251/skin.8.supp.375.